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of 11 (73%) patients indicated that shocks < 1 J were painful and all required 
sedation at a shock energy level > 2 J. 
Conclusions: (1) Internal atrial defibrillation could be safely and effectively 
performed in all patients in this series. (2) However, only in 36% of the 
patients atrial f~rillation could be terminated with an energy _< 3 J. Thus, 
only a minority of patients may benefit from an Implantable atrial defibrillator 
capable of storing a maximum shock energy of 3 J. (3) Pain perception may 
have a major impact on quality of life in patients with an imptsntable atrial 
defibrillator since the majority of the patients (73%) reported severe pain at 
shock energies < 1 J. 
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~ Safety of  Transvenoua Atrial Defibril lation in 
Patients With Monomorphic Ventricular Tachycardia 
and Heart Oisease 
Andrea Natale, Margaret M. Keamey, M. Joan Brandon, Mary J. Geiger, 
Helen Barold, Gery Tomeesoni, Virginia Kent, Keith H. Newby. VA Medical 
Center~Duke University,, Durham, NC 
History of ventricular techycardia (VT) and depressed ejection fraction may 
affect ransvenous atrial defibrillation (AD) increasing the likelihood of shock- 
related arrbythmias. In 25 pts with VT (mean age 65 4- 8 years; EF 29 4- 9%) 
we assessed the safety of AD using 2 catheters in the right atrial appendage 
and coronary sinus. In each pt, AD was performed with increasing energy 
starting at 0.5 joules. The protocol was performed both in drug free state 
and during Isoproteren01 infusion. In 5 pts AD was attempted during VT 
and atrial pacing with AV conduction at the same rate of VT. Shocks were 
synchronized using a Medtrenic external defibrillator model 2394. A total of 
398 shocks were analyzed. No ventricular tachyarrhythmias were observed 
after shocks synchronized on the R wave. In 3 pts ventricular fibrillation 
followed inappropriate shocks on the T wave. In all 3 pts, T wave shocking 
was seen only during isoproterenol infusion. Shocks delivered during VT 
always resulted in acceleration of VT (1 pt) or de~,eneretion to VF (4 pts). 
However in the same pts shocks during atrial pacing with ventricular ate 
similar to VT did not induce ventricular arrhythmlas. In conclusion: i} In pts 
with VT transvenous atrial defibrillation is safe when shocks are propedy 
synchronized. 2) Atrial defibrillation during VT appears proarrhythmic. 3) 
Whether lsoprotsrenof infusion increases the likelihood of inappropriate T
wave oversensing needs further evaluation. 
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~ Repeated Internal Low-Energy Cardiovereion of  
Atrial Fibrillation 
Eckhard Ait, Richard Ammer, Claus Schmitt, Jay Pasquantonlo, 
Fred Evans. I. Mad. Kfinik, K#ns~um rechts der Isar, Technical University 
M~nchen, Germany 
Background: The goal of this study was to determine if repeated internal 
cardioversion (intCV) of atrial fibrillation (AF) required the same energy for 
cenvemion as previous successful intCVs. 
Methods: IntCV was successfully performed in 51 of 56 pts by delivering 
3 ms/2 ms biphasic shocks (Ventritex HVS 02, Sunnyvale CA) between 
two custom.made tntracardiac electrode catheters (61=, Elecath Inc., Rahway 
NJ). The shocks ware R-wave triggered, voltage was increased by 40V per 
shock in intervals until sinus rhythm was achieved. Pts were sedated with 
Midazolam. After a mean follow.up of 11 ± 6 months, 20 pts experienced a
second episode of AF. In 8 of these 10ts (age 59 4- 10 years, initial episode 
AF persisting for 7.1 :E 2.5 months, with a mean left atrial echocardiographlc 
diameter of 56.6 ~ 2.4 mm) intCV was attempted a second time after a mean 
AF relapse duration of 1.3:1= 0.9 months. 
Results: Sinus rhythm was restored with a mean energy of 6.4 4- 2.1 J 
(range 1.0-10.2 J) in the first and 3.8 :l: 1.7 J in the second intCV (p < 0.05) 
In all 8 pts. 
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Conclusions: Repeat intCV requires less energy than primary intCV of 
chronic AF given that the second episode is of shorter duration than the first. 
A large number of pts are ineligible for atrial defibrillator implantation due 
to atria[ defibrillation thresholds (DFTs} exceeding the acceptable pain level. 
This study implies that such pts would have considerably lower DFTs, and as 
a result less pain, if their AF was quickly detected and addressed, such as in 
the case of an implanted atrial defibrillator. Therefore, these pts may indeed 
be suitable candidates for atrial defibrillator implantation. 
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[790-1 I In Vivo Nitrate Tolerance Is Not Associated With 
Decreased Production of  Nitric Oxide 
Jom S. Laursen, Alexander Mulsch, Simon Trautner, Petr Mordvintcev, 
Soren Boesgaard, Rudi Busse, Jan Ndershvite. Med. Dept. 8, 
Rigshospitafet, Univ. of Copenhagen, Denmark; Center of Physiology, JW 
Goethe Univ. FrankfurftMain, Germany 
Reduced bioconversion of nitroglycerin (NTG) to nitric P.xide (NO) is regarded 
as a major contributor to the development of nitrate tolerance (Tot). However, 
the validity of this hypothesis has not been examined. We measured produc- 
tion of NO in vascular tissues from nitrate tolerant and non-tolerant rats by in 
vivo spin-trapping of NO. Conscious rats received an Lv. Infusion of NTG (1 
mg/hr, Tel + NTG group, (n ~ 8)) or NTG vehicle. (placebo + NTG group, (n 
= 82) ) for 72 hrs and NO was trapped by d ieethy ld i th io~ate  (DETC) and 
Fe +-citrate during an additional final 20-rain infusion of NTG (6-5 mg/kg), 
Baseline NO production was measured in another group of rats not treated 
with NTG (n = 8, control). Tolerance was documented after 72 h. by an 83% 
reduction in the hypotsnsive response to a NTG bolus (From 24 ± 3 (0 hrs) 
to 2:1: I mmHg ~.72 hre}; p < 0.05). Tissues were removed and analyzed 
for NOFe(DETC)~ complexes by ESR spectroscopy. Data are presented as 
nmot NO/g tissue/20 min. 
Mean (~ Sem) Aorta V. ¢ava Heart NTG Responses 
(ram HO} 
Tel + NTG i18:1:0.3 2.2 =t= 0.3 5.1 4-0.5 24 ~3vs2± 1 
Placebo + NTG 0.9 ± 0.2 1.2:1:0.2 1.7 =t= 0.2 25 .E 3 vs 2 ± 1 
Control 0±0 0±0 0.2±0.01 27:1:3 
The results suggest hat the amounts of NO produced from NTG in homo- 
dynamically nitrate tolerant rats {TeL -*- NTG) are higher or similar to the 
amounts of NO produced in non tolerant rats (placebo + NTG, p < 0.05). 
It is concluded that the in vivo NTG tolerance is not caused by a reduced 
bioconversion of NTG to NO. Instead, tolerance may be associated with a 
reduction of the biological activity of NO. 
10:45 
[ "~ '~ Antiplatelet Effect o f  Nitroglycerin Is Primarily 
Mediated by Glutsthlene-a-Transfersses In Human 
Plasma 
Liying Chen, Jawahar L. Mehta. University of Florida, Ga/nesvi/le, FL; VA 
Medical Center, Gainesville, FL 
Current hypothesis relative to the mechanism of action of NTG involves 
metabolic activation of NTG to nitric oxide (NO) by glutathione-s-transferasas 
(GST). Whereas GST metabolizes organic nitrates in the liver, it is unclear if 
these enzymes are present in human plasma or platslets, and are involved 
in the antiplatefet e,'feefs of NTG. We investigated the rote of GST in the 
inhibition of platalet aggregation by NTG. Different concentrations of NTG 
(I-100/~g/ml) were Incubated with platelet-dch plasma or washed platelet 
suspension, and aggregation induced by ADP or thrombin. NTG caused 
a concentration-dependent i hibition of platelet aggregation in platelet.fich 
plasma with ICe0 ~ 50 ~g/mL The aggregation inhibitory effect of NTG 
was not observed in washed platetet suspension, In contrast, authentic NO 
caused about 50% decrease in aggregation in washed platelet suspen- 
sion. The aggregation inhibitory effect of NTG in platelet-ri~ plasma was 
oxyhemnglobin (Hb)-sensitive. The aggregation inhibitory effect of NTG in 
platelet-rich plasma was potentiated by propyithlouracil (600/~g/ml), a GST 
inducer, and antagonized by ketoprofen (100 p.g/mI), a GST inhibitor. These 
phenomena were not observed in washed platslef suspension. Since Hb 
cannot penetrate platalats, revemef of the effect of NTG by Hb must have 
been due to removal of NO from the extracellular medium. This concept 
was confirmed in other studies, wherein NTG (100 #g/ml) increased nitrite 
levels 3 fold in platslet-rich plasma after 60 rain incubation. On the other 
